Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They don’t care of st Patrick. They don’t drink alcohol.
They just on a St Paddy’s Day hiatus??
I ignored them all as well. Guess you could say that we “shorted” their stock
Haha, what an income that must be, lolololol!!!
Eltp
I cut their main source of income. lol.
Yep, they get paid per response!!
Eltp
Just put that guy on ignore. It drives them CRAZY when you ignore them. I got like 50 messages from their alt accounts talking trash to me and wigging out for putting them on ignore 🤣
Yes, it is common for the brand to be discontinued after several generics are on the market. It is a business decision. I don't know the method for filing an ANDA after the brand name is discontinued. I am sure it can be done.
That’s interesting. Is it common for the brand to discontinue the original drug once several generic alternatives are available?
Do you know if additional generics can still get approved after the brand is discontinued? Can they still rely on the brand’s initial trial data for bioequivalency even if the company has discontinued the branded/original drug?
Anytime before THE Buyout works for me.
GLTY
Locked $$ Loaded
ELTP
BTW, the brand name product, Revia, is discontinued.
The company I work for buys from Cardinal wholesaler. Sun is their preferred brand. I have seen Sun, Tagi, Accord, and Avet. There are others listed, but I have not seen them myself. Right now the Cardinal website shows NOTHING available to order. I notice the FDA shortage page says Elite product is available. Hopefully Cardinal gets some soon!
James, curious...how many sellers of Naltrexone do you see normally?
Naltrexone is a small market drug, but there is a patient population that needs it. I am sure sales are significantly higher because of the shortage. For companies with a huge portfolio of drugs (e.g. Sun) Naltrexone is low importance, but for Elite it’s worth the effort.
I have more funds coming for end of week or Monday.
GLTY
That, Doug Plassche and crew actually getting the API from raw to finished product and Kirko lining up customers (though I’m sure Adderall is largely selling itself currently). And our 3PL partner getting said product to pharmacies and such.
Several potential points of failure but Elite has managed the process pretty well so far.
Considering the Adderall shortages, is now a good time to buy ELTP shares?
Yes they did - Thanks to Nasrat who has API when all other companies do not
Elite has done a great job keeping their products mostly available during times of shortage.
Thanks again, I saved the page.
The Bollinger Bands also appear to be positive. It worked for the Tin Man so we may be off to see the Wizard. Oops, wrong Bolger.
Seriously, it looks like Elite was subjected to spoofing which on low volume and thin prices can cause unreasonable moves in both directions defying fundamentals. The attorneys for NWBO filed an amended complaint last week in their Market Maker federal suit asserting Loss Causation regarding this key issue which permits Market Makers to F around with stocks they are supposed to support by creating an orderly market.
When this happens, instead of panicking, investors who want to be successful should take advantage of the temporary pullback by continuing to accumulate. I know I did.
Shortages:
FDA shortage link for Adderall
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet&st=c&tab=tabs-1
FDA shortage link for Vyvance
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Lisdexamfetamine%20Dimesylate%20Capsule&st=c
FDA shortage link for Concerta
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release&st=c
FDA shortage link for Naltrexone
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Naltrexone%20Hydrochloride%20Tablet&st=c
THX, I could not find Concerta
Top Muslim Populations by Country
Pakistan 240.8M
Indonesia 236M
India 200M
Happy Ramadan! Enjoy the month of peace!
ELTP double bottom in, quite often they are explosive reversals to the upside. Trading to accumulate. vhttps://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=&insttype=Stock&symb=eltp&x=23&y=8&time=7&startdate=1%2F4%2F1999&enddate=2%2F4%2F2018&freq=1&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=0&maval=9&uf=8&lf=32&lf2=2&lf3=268435456&type=4&style=320&size=3&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=15
FDA shortage link for Vyvance
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Lisdexamfetamine%20Dimesylate%20Capsule&st=c
FDA shortage link for Concerta
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release&st=c
Elite has four ANDAs, ALL filed and under FDA review:
1. antimetabolite ANDA used to treat inflammatory arthritis.
2. dopamine agonistANDA for the treatment of Parkinson's.
3. ANDA for treatment of pain management .
4. CNS stimulus ANDA used for attention deficit disorder.
Do a link for vyvance: lisdexamfetamine
Extreme Shortage !!
What’s the earliest we can get approval ?
My thoughts exactly NASDAQ2020
Where are the Bashers? Must be something Huge coming this week ?
ELTP
I’m hanging like a monkey with arthritis in my hands and feet LOL Fast track FDA hope your day is well NASDAQ2020! ELTP $$$$$$$$$
Vyvance fast track approval !
I think a lot of it is hand to mouth and when they get their quota. Once the quote is used up, they will be back in shortage. They don't seem to get a rolling quota.
Anecdotal info: From my viewpoint the Adderall shortage is almost over. Yes, some manufacturers have backorders, but there is at least one manufacturer in stock on all the strengths. OTOH, Vyvanse generic is completely unavailable in any strength from any manufacturer.
BIG-BLUE-SUPPORT Chart-Line - TESTED - HOLDS>>>
So Price has gone all the way back to test October 2023 levels, as the FUNDAMENTALS now are so much stronger now than in October. Obviously, many longer term investors saw their paper gains getting lost, so they have sold and taken profits from many years before when ELTP struggled to cross the .05 level. Now there has been HUGE ACCUMULATION above the .13 BIG BLUE SUPPORT line, and the chart certainly shows that the bottom may be in. RSI has bounced twice off of 30, and the accum/dist line has turned... Could be a great area for investing/adding shares, in my opinion.
Thanks for sharing
Very interesting
Irish car bombs… been a minute since I’ve had one of those but they’re legit 👌
Long live the King 👑 🗡️
$ELTP$
Posted by me back in 2020. Turns out I was RIGHT~!
This low volume is just part of the pattern that’s been going on for months. We will go up a bit next week.
Been a very low volume week in general. Spring vacations kicking in?
That’s actually a very interesting observation. I have been actually checking for days with less activity here and checking to see what/if any holidays were occurring elsewhere in the world to try and narrow down where some of these folks are. This is the quietest this board has been as long as I can remember. Especially for a Friday.
The other reason could just be that this stock is ready to go back north.
Nice day here!! Seems the ants disappeared for regrouping.
Eltp!!
Nice move up today!! 3 up days in a row.
Thanks JamesF1. Many who post here realize the Company is WAY undervalued.
The narrative of too many outstanding shares is way overblown. Always has been.
The narrative of consecutive quarters CFP is thrown to garbage as well.
The narrative that Mikah is a hindrance to a buyout is ABSURD~! NH certainly doesn't think that~!
It only ADDS value going forward~! My opinion.
The agendas are clear. Let the FUDsters continue their rants. They now know where King Jimmy Joe stands.
The only thing I would wish for at this time is Moe Money with which to accumulate a couple of million shares.
Like I've posted I have a nice position, but opportunities like Elite don't come knocking every day.
By the way, I do live in a trailer down by the river and am a motivational speaker........ RIP Chris Farley... too funny and one of my favorites of all time.
Lets GO~! 🚀🚀🚀🚀🚀🚀
$ELTP baby~!
Do we close in upper .14s today? One 20 buy pushes through .144 ask.
Yeah, baby
Followers
|
957
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
398167
|
Created
|
03/24/09
|
Type
|
Free
|
Moderators jimr1717 mrwrn2010 NASDAQ2020 IB_ namtae Dr JoeBarducci |
Elite needs a Board of Directors that represents all shareholders !!!
Senior Moderator: IB_
Posted: 6/5/23
________________________________________________________________________________________________________________
Elite Pharmaceuticals, Inc. |
Website | Location | Employees | Facility | CEO |
www.elitepharma.com | Northvale, New Jersey | 53 | 55,000 sq ft | Nasrat Hakim |
Products & Pipeline | ||||
Drug | Market Size | Status | Competitors | Marketed By |
Adderall IR | 389.8 M | On Market | 15 | Elite |
Adderall XR | 1.56 B | On Market | 10 | Elite & Prasco |
Dantrolene | 6.3 M | On Market | 2 | Elite |
Isradipine | 5.5 M | On Market | 1 | Elite |
Loxapine | 5 M | On Market | 2 | Elite |
Phendimetrazine | 4.5 M | On Market | 4 | Elite |
Trimipramine | 2 M | On Market | 1 | Elite |
Naltrexone | 16 M | On Market | 5 | Precision Dose |
Phentermine Capsules | 7.5 M | On Market | 6 | Precision Dose |
Phentermine Tablets | 40 M | On Market | 8 | Precision Dose |
Vigabatrin | 233.7 M | Approved (On Hold - Trademark dispute) | 13 | Pyros |
Doxycycline | 85 M | Approved (Discontinued) | 9 | ---------- |
Tylenol with Codeine | 45 M | Approved (On Hold - Opioid) | 5 | ---------- |
Dopamine Agonist | 12 M | Filed with FDA - 22 Dec 2022 | ---------- | ---------- |
Antimetabolite | 42 M | Filed with FDA - 20 Apr 2023 | ---------- | ---------- |
Generic OxyContin | 720 M | Filed with FDA - 17 Aug 2023 | ---------- | ---------- |
Generic Vyvanse | 5.1 B | Filed with FDA - 21 Dec 2023 | 14 | ---------- |
Generic Concerta | 1.16 B | In Development (Final Stages) | 9 | ---------- |
Financials | ||||
Fiscal Year | Revenue | Change | Net Income | Change |
2019 | 7,568,508 | ---------- | (9,279,321) | ---------- |
2020 | 17,994,639 | +137.76% | (2,240,351) | +75.86% |
2021 | 25,380,749 | +41.05% | 5,088,421 | +327.13% |
2022 | 32,262,117 | +27.11% | 8,898,245 | +74.87% |
2023 | 34,155,114 | +5.87% | 3,561,846 | -59.97% |
2024 Q1 | 8,980,076 | +17.04% | 1,141,809 | +273.28% |
2024 Q2 | 14,157,185 | +64.90% | 14,934,601 | +866.0% |
2024 Q3 | 15,538,800 | +68.00% | 3,500,000 | +80.0% |
FY 2024 Projected | Minimum Projected: 50,000,000 | Minimum YOY Projected Increase of 68.31% | ||
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |